Skip to content

Promonitor-ANTI-ADL

by Progenika Biopharma, S.A. Spain EUDAMED

Ref 5090230000 EMDN W0102080702

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number8437013457Promonitor004GV Basic UDI-DIDate6 Jun 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
5090230000
Primary DI / UDI-DI
08437013457484
Basic UDI-DI
8437013457Promonitor004GV
Direct Marketing DI
08437013457484
EMDN Code
W0102080702 Adalimumab
Device Class
Class B
Market of Registration
Spain

Manufacturer details

EUDAMED SRN
ES-MF-000001005

Other devices from Progenika Biopharma, S.A.

See all devices from Progenika Biopharma, S.A. →

Properties & raw data

Show properties, registry sources and raw records
  • Human Tissues
  • Animal Tissues
  • Professional Testing
Other properties (8)
  • Sterile: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (1)

  • EUDAMED 79e5f219-1af3-4c84-8eb0-9ecaaf94cd64 61 fields · synced 24 Oct 2026